© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Northeast Asia

  • It’s tough being a banker these days, and not just because the mouth-watering pay cheques and bonuses that came with the job have been gradually drying up.
  • Fangdd Network Group, an online platform for real estate agents, is planning an IPO on the Nasdaq, having filed draft documents with the US securities regulator this week.
  • State-owned hydropower company China Three Gorges Corp made a rare visit to the dollar bond market, extending its maturity profile to 30 years.
  • Health and Happiness International Holdings and Shui On Land have both made swift returns to the loan market for tightly priced deals.
  • Bank of China broke new ground for Asia this week with the region’s first floating rate bond linked to the secured overnight financing rate (Sofr). But a host of challenges around payment calculations and liquidity mean other issuers will be slower to embrace this new benchmark. Addison Gong reports.
  • Chinese property company Ronshine China Holdings brought its 2022 notes to the market again on Wednesday, tapping the 8.75% bonds for a second time and adding $265m to its coffers.
  • Japanese Sumitomo Mitsui Financial Group (SMFG), the holding company for SMBC, returned to Australian dollars on Wednesday after two years away from the currency.
  • The Export-Import Bank of China (Chexim) came to the bond market in two currencies on Tuesday to raise $1.068bn, pricing the euro tranche at an impressive zero coupon.
  • Q&K International Group has filed for a Nasdaq IPO of American Depository Shares (ADS) with an aim to raise up to $100m.
  • Hyundai Card, a South Korean credit card company, has issued a request for proposals to banks to work on its planned IPO.
  • Semiconductor Manufacturing International Corp (SMIC) and traditional Chinese medicine maker Sinopharm Group are both plotting their returns to the Panda bond market.
  • Investors have mixed feelings about bonds from Chinese property companies, but a likely supply-demand rebalance could signal yet another honeymoon period for the sector.